Influence of complex application of heliox therapy and acupuncture on maximally corrected visual acuity in patients with acute form of central serous chorioretinopathy

Vyacheslav M. Sheludchenko , Alina K. Drakon

Russian Journal of Physiotherapy, Balneology and Rehabilitation ›› 2022, Vol. 21 ›› Issue (2) : 91 -95.

PDF
Russian Journal of Physiotherapy, Balneology and Rehabilitation ›› 2022, Vol. 21 ›› Issue (2) : 91 -95. DOI: 10.17816/rjpbr111036
Original studies
research-article

Influence of complex application of heliox therapy and acupuncture on maximally corrected visual acuity in patients with acute form of central serous chorioretinopathy

Author information +
History +
PDF

Abstract

BACKGROUND: Central serous chorioretinopathy is a socially significant problem, as it is one of the most common diseases of the retina. It is more common in males of working age.

AIM: to evaluate the effect of the combined use of heliox therapy and acupuncture on the most corrected visual acuity in patients with acute central serous chorioretinopathy.

MATERIAL AND METHODS: The study included 34 men (34 eyes) with central serous chorioretinopathy, whose mean age was 36±2.3 years. The patients were divided into 2 groups comparable according to clinical and laboratory data: the main one ― 22 people, average age 32±3.1 years, who in the first two weeks received a complex of physiotherapeutic treatment, including: heliox 21, for a course of 10 daily procedures and acupuncture, also for a course of 10 daily procedures, and a control ― 12 people, average age 34±1.5 years, who, after consulting a neurologist, were prescribed medication (light sedatives, the Nutrof vitamin complex, diuretics 1 time in 3 days with restoration of electrolyte balance, alcohol restriction), which served as a background in the main group.

Visometry (visual acuity) was used to assess the effectiveness of treatment. Before treatment, after 2 weeks, after 1 month, 3 months, 6 months, 12 months.

RESULTS: Before treatment in patients with acute central serous chorioretinopathy, the maximum corrected visual acuity was reduced by 44.2% compared to the norm ― 0.95±0.05 (p <0.001) and comparable in the main group 0.54±0.05 and in the control group 0.53±0.05 (p=0.901). The maximum increase in visual acuity in patients of the main group was already two weeks later, with a subsequent increase in the indicator during the year, approaching the normal values at the last observation point (1 year). In addition, all patients after treatment noted a decrease in the intensity or exclusion of metamorphopsia. In the maximally corrected visual acuity control group, significantly less significant results were obtained at all control points.

CONCLUSION: Under the influence of the combined use of heliox therapy and acupuncture in patients with acute form of central serous chorioretinopathy, a more pronounced and persistent increase in maximally corrected visual acuity occurred compared to drug treatment.

Keywords

central serous chorioretinopathy / rehabilitation / physiotherapy / ophthalmic rehabilitation / oxygen-helium therapy / acupuncture

Cite this article

Download citation ▾
Vyacheslav M. Sheludchenko, Alina K. Drakon. Influence of complex application of heliox therapy and acupuncture on maximally corrected visual acuity in patients with acute form of central serous chorioretinopathy. Russian Journal of Physiotherapy, Balneology and Rehabilitation, 2022, 21(2): 91-95 DOI:10.17816/rjpbr111036

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Drakon AK, Pateyuk LS, Sheludchenko VM, Korchazhkina NB. Modern approaches in the treatment of central serous chorioretinopathy. Review. Oftalmologiya. 2021;18(S3):660–665. (In Russ). doi: 10.18008/1816-5095-2021-3S-660-665

[2]

Дракон А.К., Патеюк Л.С., Шелудченко В.М., Корчажкина Н.Б. Современные подходы в лечении центральной серозной хориоретинопатии. Обзор // Офтальмология. 2021. Т. 18, № S3. С. 660–665. doi: 10.18008/1816-5095-2021-3S-660-665

[3]

Shpak AA. Optical coherence tomography: problems and solutions. Moscow: Oftalmologiya; 2019. 148 p. (In Russ). doi: 10.25276/978-5-903624-44-7

[4]

Шпак А.А. Оптическая когерентная томография: проблемы и решения. Москва: Офтальмология, 2019. 148 с. doi: 10.25276/978-5-903624-44-7

[5]

Certificate of state registration of the database No. 2021621635 Russian Federation. Database of scientific researches on medical rehabilitation of ophthalmic patients: No. 2021621519: Appl. 07/21/2021: publ. July 30, 2021. Mikhailova A.A., Kotenko K.V., Korchazhkina N.B., et al.; applicant Federal State Budgetary Scientific Institution Russian Scientific Center for Surgery named after Academician B.V. Petrovsky, Federal State Budgetary Scientific Institution Research Institute of Eye Diseases. (In Russ).

[6]

Свидетельство о государственной регистрации базы данных № 2021621635 Российская Федерация. База данных научных исследований по медицинской реабилитации пациентов офтальмологического профиля: № 2021621519: заявл. 21.07.2021: опубл. 30.07.2021. Михайлова А.А., Котенко К.В., Корчажкина Н.Б., и др.; заявитель Федеральное государственное бюджетное научное учреждение «Российский научный центр хирургии имени академика Б.В. Петровского», Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт глазных болезней».

[7]

Certificate of state registration of the database No. 2021621882 Russian Federation. Database of scientific research on the use of electrophoresis of medicinal substances in ophthalmology: No. 2021621757: Appl. 08/26/2021: publ. 09/06/2021. Mikhailova A.A., Kotenko K.V., Korchazhkina N.B., et al.; applicant Federal State Budgetary Scientific Institution Russian Scientific Center for Surgery named after Academician B.V. Petrovsky, Federal State Budgetary Scientific Institution Research Institute of Eye Diseases. (In Russ).

[8]

Свидетельство о государственной регистрации базы данных № 2021621882 Российская Федерация. База данных научных исследований по применению электрофореза лекарственных веществ в офтальмологии: № 2021621757: заявл. 26.08.2021: опубл. 06.09.2021. Михайлова А.А., Котенко К.В., Корчажки- на Н.Б., и др.; заявитель Федеральное государственное бюджетное научное учреждение «Российский научный центр хирургии имени академика Б.В. Петровского», Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт глазных болезней».

[9]

Vybornaya TR, Davydov DV. Partial atrophy of the optic nerve: pathogenesis and methods of treatment (Literature review) Moscow Sur J. 2016;(6):20–24. (In Russ).

[10]

Выборная Т.Р., Давыдов Д.В. Частичная атрофия зрительного нерва: патогенез и методы лечения (обзор литературы) // Московский хирургический журнал. 2016. № 6. С. 20–24.

[11]

Bezdetko PA. Experience in the use of transcutaneous electrical stimulation of the optic nerve in patients with optic nerve atrophy of various origins. Oftalmologicheskii zhurnal. 1995;(5-6):307–309. (In Russ).

[12]

Бездетко П.А. Опыт применения чрескожной электростимуляции зрительного нерва у больных с атрофией зрительного нерва различного генеза // Офтальмологический журнал. 1995. № 5-6. С. 307–309.

[13]

Khasieva GG, Korchazhkina NB, Dragon AK, Ryzhova LS. Modern physiotherapeutic technologies of rehabilitation treatment for impaired functions of the organ of vision. Russian journal of the physial therapy, balneotherapy and rehabilitation. 2015;14(6):28–31. (In Russ).

[14]

Хасиева Г.Г., Корчажкина Н.Б., Дракон А.К., Рыжова Л.С. Современные физиотерапевтические технологии восстановительного лечения при нарушенных функциях органа зрения // Физиотерапия, бальнеология и реабилитация. 2015. Т. 14, № 6. С. 28–31.

[15]

Korchazhkina NB, Drakon AK. Eye diseases. In: Physical and rehabilitation medicine: national guidelines. Moscow: GEOTAR-Media; 2020. Р. 518–524. (In Russ).

[16]

Корчажкина Н.Б., Дракон А.К. Заболевания глаз // Физическая и реабилитационная медицина: национальное руководство. Москва: ГЭОТАР-Медиа, 2020. С. 518–524.

[17]

Shvets DA. Pathogenetic rationale for the use of helium-oxygen therapy in the correction of hemorheological and autonomic dysfunctions in hypoxic conditions of obstructive respiratory genesis [dissertation abstract]. Saransk; 2006. 34 р. (In Russ).

[18]

Швец Д.А. Патогенетическое обоснование применения гелий-кислородной терапии в коррекции гемореологических и вегетативных дисфункций при гипоксических состояниях обструктивно-респираторного генеза: Автореф. дис. ... канд. мед. наук. Саранск, 2006. 34 с.

[19]

Shogenova LV. The effectiveness of heliox therapy in patients with obstructive pulmonary diseases in acute respiratory failure [dissertation abstract]. Moscow; 2003. 28 р. (In Russ).

[20]

Шогенова Л.В. Эффективность терапии гелиоксом больных обструктивными болезнями легких при острой дыхательной недостаточности: Автореф. дис. ... канд. мед. наук. Москва, 2003. 28 с.

RIGHTS & PERMISSIONS

Sheludchenko V.M., Drakon A.K.

AI Summary AI Mindmap
PDF

124

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/